SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001295947-21-000009
Filing Date
2021-02-04
Accepted
2021-02-04 06:21:42
Documents
93
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q pbh-20201231.htm   iXBRL 10-Q 2122928
2 EX-31.1 exhibit3112020-12x31.htm EX-31.1 11382
3 EX-31.2 exhibit3122020-12x31.htm EX-31.2 11260
4 EX-32.1 exhibit3212020-12x31.htm EX-32.1 5424
5 EX-32.2 exhibit3222020-12x31.htm EX-32.2 5505
11 pbh-20201231_g1.jpg GRAPHIC 66137
  Complete submission text file 0001295947-21-000009.txt   10115665

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pbh-20201231.xsd EX-101.SCH 55683
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pbh-20201231_cal.xml EX-101.CAL 138268
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pbh-20201231_def.xml EX-101.DEF 295078
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pbh-20201231_lab.xml EX-101.LAB 757795
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pbh-20201231_pre.xml EX-101.PRE 500920
12 EXTRACTED XBRL INSTANCE DOCUMENT pbh-20201231_htm.xml XML 2067477
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32433 | Film No.: 21588765
SIC: 2834 Pharmaceutical Preparations